Treatment of Anemia in Low Risk Myelodysplastic Syndromes With Granulocyte–macrophage Colony-Stimulating Factor Plus Recombinant Human Erythropoietin

Leukemia - United Kingdom
doi 10.1038/sj.leu.2401442
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Low-Resolution Structure of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor

Journal of Molecular Biology
Structural BiologyMolecular BiologyBiophysics
1991English

Clozapine-Associated Agranulocytosis Treatment With Granulocyte Colony-Stimulating Factor/Granulocyte-Macrophage Colony-Stimulating Factor

Journal of Clinical Psychopharmacology
PsychiatryMental HealthPharmacology
2017English

Human Recombinant Granulocyte-Macrophage Colony-Stimulating Factor: A Multilineage Hematopoietin

Science
MultidisciplinaryPhilosophy of ScienceHistory
1985English

Treatment With Molgramostim (Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor, Rhugm-Csf, Mielogen) and Lenograstim (Granulocyte-Colony Stimulating Factor) Improves Experimental Colitis in Rats

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2019English

Effects of Recombinant Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor on Platelet Aggregation in Healthy Volunteers

Turkiye Klinikleri Journal of Medical Sciences
Medicine
2015English

Granulocyte-Macrophage Colony-Stimulating Factor

Reactions Weekly
1994English

Granulocyte-Macrophage Colony-Stimulating Factor

Reactions Weekly
1990English

Granulocyte-Macrophage Colony-Stimulating Factor

Reactions Weekly
1991English

Granulocyte-Macrophage Colony Stimulating Factor

Reactions Weekly
1995English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy